HCID 57143475, compound → HCID 57145422, compound
Reaction equation
[CH3:1][N:2]1[C:6](=[N:7][CH:8]([Cl:15])[CH:9]([Cl:14])[C:10]([Cl:13])([Cl:12])[Cl:11])[C:5](=[O:16])[N:4]([C:17]2[CH:22]=[CH:21][CH:20]=[CH:19][C:18]=2F)[C:3]1=[O:24].[F:25][C:26]1C=[CH:30][CH:29]=[CH:28][C:27]=1N1C(=NC(Cl)C(Cl)C(Cl)(Cl)Cl)CN(C)C1>>[F:25][C:26]1[CH:27]=[CH:28][CH:29]=[CH:30][C:1]=1[N:2]1[C:6](=[N:7][CH:8]([Cl:15])[CH:9]([Cl:14])[C:10]([Cl:12])([Cl:11])[Cl:13])[C:5](=[O:16])[N:4]([CH:17]2[CH2:18][CH2:19][CH2:20][CH2:21][CH2:22]2)[C:3]1=[O:24]Participants
3
Procedure
Similarly the reverse 1-position-3-position isomers of each of the above prepared compounds are prepared by using the corresponding position isomer of formula A as the starting material. For example by using 1-methyl-3-(2-fluorophenyl)-5-(1,2,3,3,3-pentachloropropyl)imino-1,3-diazolidine-2,4-dione in place of 1-(2-fluorophenyl-3-methyl-5-(1,2,3,3,3-pentachloropropyl)imino-1,3-diazolidine the following compounds (as well as the other position isomers of the above products) are prepared:
Workup
- customSimilarly the reverse 1-position-3-position isomers of each of the above prepared compounds are prepared
- customare prepared
Sources & evidence
- ORD record
- ord-4bfb84d40bba49d1a7442b4005f6faf0
- Source dataset
- uspto-grants-1981_02
- Patent number
- US04248620
Reaction notes
Loading…